Pfizer CEO Read urges patience as drug maker reorganizes, mulls breakup
This article was originally published in Scrip
Executive Summary
Pfizer CEO Ian Read asked investors to show some patience as the big drug maker reorganizes into separate businesses, a move analysts see as the first step of a company breakup.